Latest News for: oncology

Edit

Global Nanomedicine Markets, 2015-2020, 2020-2025F, 2030F - Focus on Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Clinical Oncology, ...

MENA FN 04 Nov 2021
(MENAFN - PR Newswire) DUBLIN, Nov. 3, 2021 /PRNewswire/ -- The "Nanomedicine Global Market Report 2021. COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's ... .
Edit

Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Sierra Oncology Inc)

Public Technologies 03 Nov 2021
SAN MATEO, Calif.--(BUSINESS WIRE)-- Sierra Oncology, Inc ... About Sierra Oncology. Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer ... Sierra Oncology ... Sierra Oncology Inc.
Edit

Targeted Oncology Therapeutics: Success of CAR-T Technology for the Treatment of Haematology Cancers

MENA FN 03 Nov 2021
(MENAFN - GlobeNewsWire - Nasdaq) Dublin, Nov. 03, 2021 (GLOBE NEWSWIRE) -- The "Targeted Oncology Therapeutics. Hematology Cancers" report has been added to ResearchAndMarkets.com's offering ... .
Edit

Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Business Wire 03 Nov 2021
SAN MATEO, Calif.--(BUSINESS WIRE)--Sierra Oncology, Inc ... Oncology’s 2018 Equity Inducement Plan.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Clovis Oncology Inc)

Public Technologies 03 Nov 2021
) Ownership Submission FORM 4. Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C ... 1. Name and Address of Reporting Person * ... 2 ... Clovis Oncology, Inc ... C/O CLOVIS ONCOLOGY, INC ... 3 ... 4 ... 6 ... C/O CLOVIS ONCOLOGY, INC ... Clovis Oncology Inc.
Edit

Day One Announces Presentation at 2021 Connective Tissue Oncology Society (CTOS) Virtual Annual ...

The Baytown Sun 03 Nov 2021
DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for patients of all ages with genomically-defined cancers, today announced an upcoming poster presentation at the 2021 Connective Tissue Oncology Society (CTOS) Virtual Annual Meeting, being held from November 10-13, 2021.
Edit

Global Nanomedicine Markets, 2015-2020, 2020-2025F, 2030F - Focus on Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics

PR Newswire 03 Nov 2021
They are nanoscale materials that are used in diagnosis and treatment procedures in oncology, cardiology, infectious diseases, orthopedics, and other medical areas ... The different forms of modality include diagnostics, treatments and are used in clinical oncology, infectious ...
Edit

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1 Dose Expansion Study of TP-1287 in Patients with Sarcoma

PR Newswire 03 Nov 2021
Andrews, Chief Executive Officer, Global Head of Oncology, Sumitomo Dainippon Pharma Oncology, Inc (SDP Oncology) ... About Sumitomo Dainippon Pharma Oncology. Sumitomo Dainippon Pharma Oncology, Inc., is a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. As a global oncology organization with teams in the U.S.
Edit

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1 Dose Expansion Study of ...

Daily Times Chronicle 03 Nov 2021
Andrews, Chief Executive Officer, Global Head of Oncology, Sumitomo Dainippon Pharma Oncology, Inc (SDP Oncology) ... About Sumitomo Dainippon Pharma Oncology. Sumitomo Dainippon Pharma Oncology, Inc., is a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. As a global oncology organization with teams in the U.S.

Most Viewed

×